Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Viragen considers genital herpes as possible target for Omniferon

Oct. 20, 1997

No Comments

Cefluprenam: basic and clinical research on new injectable cephalosporin

Oct. 20, 1997

No Comments

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

No Comments

CS-834: a new oral carbapenem in active development at Sankyo

Oct. 17, 1997

No Comments

BIRR-4: a new cold remedy on the horizon?

Oct. 17, 1997

No Comments

Peptide drugs for treating leishmaniasis

Oct. 17, 1997

No Comments

Antiinfective and immunomodulatory micacocidin derivatives from Shionogi

Oct. 17, 1997

No Comments

Sequence of S. epidermidis revealed

Oct. 17, 1997

No Comments

Ortho describes bacterial HPK inhibitors as antibacterial agents

Oct. 16, 1997

No Comments

KRM-1648: a rifamycin derivative active against H. pylori and Mycobacterium spp.

Oct. 15, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Infection
RSS

Viragen considers genital herpes as possible target for Omniferon

Cefluprenam: basic and clinical research on new injectable cephalosporin

Shire files IND for new formulation of aciclovir

CS-834: a new oral carbapenem in active development at Sankyo

BIRR-4: a new cold remedy on the horizon?

Peptide drugs for treating leishmaniasis

Antiinfective and immunomodulatory micacocidin derivatives from Shionogi

Sequence of S. epidermidis revealed

Ortho describes bacterial HPK inhibitors as antibacterial agents

KRM-1648: a rifamycin derivative active against H. pylori and Mycobacterium spp.

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Infection RSS

Infection
RSS